HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

PROF

Profound Medical Corp

Last Close
Dec 13 • 04:00PM ET
7.40
Dollar change
-0.03
Percentage change
-0.40 		%
Healthcare • Medical Devices • Canada • NASD
Peers: ISRG BSX INMD BDX HOLX CLPT EDAP ATEC CUTR NUWE
 | Held by: DFIS DFIC
Scroll to Statements
Index- P/E- EPS (ttm)-1.34 Insider Own13.47% Shs Outstand24.66M Perf Week-1.20%
Market Cap182.48M Forward P/E- EPS next Y-0.92 Insider Trans0.00% Shs Float21.34M Perf Month-9.42%
Income-31.39M PEG- EPS next Q-0.34 Inst Own38.76% Short Float1.57% Perf Quarter-4.52%
Sales8.98M P/S20.32 EPS this Y11.41% Inst Trans-5.83% Short Ratio5.08 Perf Half Y-10.52%
Book/sh1.26 P/B5.87 EPS next Y23.41% ROA-67.74% Short Interest0.34M Perf Year-26.18%
Cash/sh1.10 P/C6.73 EPS next 5Y- ROE-90.17% 52W Range7.05 - 11.42 Perf YTD-12.84%
Dividend Est.- P/FCF- EPS past 5Y3.31% ROI-90.13% 52W High-35.20% Beta0.85
Dividend TTM- Quick Ratio5.16 Sales past 5Y36.38% Gross Margin62.02% 52W Low4.96% ATR (14)0.43
Dividend Ex-Date- Current Ratio6.12 EPS Y/Y TTM3.65% Oper. Margin-368.27% RSI (14)41.48 Volatility6.00% 5.23%
Employees131 Debt/Eq0.20 Sales Y/Y TTM39.35% Profit Margin-349.41% Recom1.00 Target Price15.30
Option/ShortYes / Yes LT Debt/Eq0.12 EPS Q/Q-45.97% Payout- Rel Volume1.37 Prev Close7.43
Sales Surprise-5.74% EPS Surprise-26.67% Sales Q/Q63.89% EarningsNov 07 AMC Avg Volume66.05K Price7.40
SMA20-5.41% SMA50-4.79% SMA200-11.26% Trades Volume90,679 Change-0.40%
Date Action Analyst Rating Change Price Target Change
Jul-23-24Initiated Lake Street Buy $16.50
Jul-16-24Upgrade Stifel Hold → Buy $9 → $12
Nov-28-23Initiated Stifel Hold $11
Aug-04-23Downgrade Raymond James Strong Buy → Outperform $20 → $200
Mar-21-23Downgrade Jefferies Buy → Hold $5.50 → $10
Sep-15-20Initiated Jefferies Buy
Dec-10-24 09:55AM
Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares
(GlobeNewswire)
Dec-06-24 09:31AM
Canadian Investment Regulatory Organization Trade Resumption - PRN
(PR Newswire) -6.72%
09:15AM
Canadian Investment Regulatory Organization Trading Halt - PRN
(PR Newswire)
09:04AM
Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares
(GlobeNewswire)
Dec-05-24 04:48PM
Profound Medical Announces Proposed Public Offering of Common Shares
(GlobeNewswire)
07:46AM Loading…
Dec-03-24 07:46AM
Profound Medical, Siemens Healthineers enter co-sales, co-marketing agreement
(TipRanks)
Dec-02-24 07:30AM
Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy
(GlobeNewswire)
Nov-26-24 07:45AM
Profound Medical to Unveil Next TULSA-AI Module, 'UA Alignment Assistant'
(GlobeNewswire)
Nov-12-24 08:00AM
Profound Medical to Participate in the Stifel 2024 Healthcare Conference
(GlobeNewswire)
Nov-08-24 12:03PM
Profound Medical Corp (PROF) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Rising Expenses
(GuruFocus.com)
Nov-07-24 04:05PM
Profound Medical Announces Third Quarter 2024 Financial Results
(GlobeNewswire) +12.00%
Nov-06-24 07:41AM
Profound Medical Corp (TSX:PRN) Q3 2024 Earnings Report Preview: What To Look For
(GuruFocus.com)
Nov-04-24 06:55AM
Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025
(GlobeNewswire) +11.56%
Oct-17-24 04:30PM
Profound Medical to Release Third Quarter 2024 Financial Results on November 7 Conference Call to Follow
(GlobeNewswire)
Oct-16-24 04:15PM
Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer
(GlobeNewswire)
05:58PM Loading…
Oct-09-24 05:58PM
Profound Medical Corp (PROF) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amidst ...
(GuruFocus.com)
Sep-20-24 08:00AM
iAccess Alpha's Buyside Best Ideas Virtual Fall Conference September 24-25, 2024
(ACCESSWIRE)
Sep-16-24 08:00AM
Profound Medical's PRO-Talk Live! Event Features the Present and Future of TULSA
(GlobeNewswire)
Sep-04-24 04:30PM
Profound Medical to Participate in Lake Street's Best Ideas Growth Conference
(GlobeNewswire)
Aug-08-24 09:57PM
PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q2 2024
(InvestorPlace)
04:05PM
Profound Medical Announces Second Quarter 2024 Financial Results
(GlobeNewswire)
Jul-18-24 04:30PM
Profound Medical to Release Second Quarter 2024 Financial Results on August 8 Conference Call to Follow
(GlobeNewswire)
Jul-11-24 07:00AM
Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases
(GlobeNewswire)
May-16-24 09:18AM
Profound Medical (PROF) Adds AI to Prostate Cancer Treatment
(Zacks)
May-15-24 05:00PM
Profound Medical Annual General Meeting of Shareholders Voting Results
(GlobeNewswire)
May-14-24 07:30AM
Profound Medical Receives U.S. FDA 510(k) Clearance for 'Contouring Assistant' AI Module that Enables Creation of an Automated TULSA Treatment Plan
(GlobeNewswire) +7.32%
May-13-24 10:46AM
Profound Medical Corp. (NASDAQ:PROF) Q1 2024 Earnings Call Transcript
(Insider Monkey)
May-09-24 08:55PM
PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q1 2024
(InvestorPlace) +13.60% -9.27%
04:05PM
Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance
(GlobeNewswire)
May-06-24 04:15PM
Growing Body of Clinical Evidence Points to the Potential of Profound Medical's TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum
(GlobeNewswire)
04:15PM Loading…
Apr-22-24 04:15PM
Profound Medical to Release First Quarter 2024 Financial Results on May 9 Conference Call to Follow
(GlobeNewswire)
Apr-09-24 07:45AM
Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference
(GlobeNewswire)
Mar-08-24 03:31PM
Profound Medical Corp. (NASDAQ:PROF) Q4 2023 Earnings Call Transcript
(Insider Monkey) -10.86%
Mar-07-24 09:54PM
PROF Stock Earnings: Profound Medical Misses EPS, Beats Revenue for Q4 2023
(InvestorPlace)
04:05PM
Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results
(GlobeNewswire)
Mar-04-24 04:30PM
Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference
(GlobeNewswire)
Mar-01-24 11:58AM
Profound Medical (PROF), Siemens Unite to Treat Prostate Cancer
(Zacks)
Feb-27-24 07:45AM
Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure
(GlobeNewswire)
Feb-15-24 04:30PM
Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 Conference Call to Follow
(GlobeNewswire)
Jan-29-24 09:08AM
Profound Medical (PROF) Soars 9.4%: Is Further Upside Left in the Stock?
(Zacks)
Jan-26-24 09:55AM
How Much Upside is Left in Profound Medical (PROF)? Wall Street Analysts Think 66.06%
(Zacks) +9.42%
Jan-16-24 04:30PM
Profound Medical Announces Non-Brokered Private Placement
(GlobeNewswire)
Jan-03-24 04:15PM
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues
(GlobeNewswire)
Dec-27-23 10:40PM
Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares
(GlobeNewswire) -8.49% -5.42%
04:15PM
Profound Medical Announces Proposed Public Offering of Common Shares
(GlobeNewswire)
Nov-08-23 07:45AM
Profound Medical to Participate in the Stifel 2023 Healthcare Conference
(GlobeNewswire)
Nov-05-23 12:07PM
Profound Medical Corp. (NASDAQ:PROF) Q3 2023 Earnings Call Transcript
(Insider Monkey)
Nov-03-23 08:00AM
Profound Medical Announces CMS Extension of Temporary 'Code' for TULSA to ASC Setting
(GlobeNewswire)
Nov-02-23 04:05PM
Profound Medical Announces Third Quarter 2023 Financial Results
(GlobeNewswire) +8.02%
Oct-19-23 04:30PM
Profound Medical to Release Third Quarter 2023 Financial Results on November 2 Conference Call to Follow
(GlobeNewswire)
Oct-10-23 04:30PM
Profound Medical 2023 Virtual Analyst & Investor Day Agenda
(GlobeNewswire)
Sep-25-23 04:05PM
Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost
(GlobeNewswire)
Sep-21-23 08:00AM
Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13
(GlobeNewswire)
Sep-19-23 04:45PM
Profound Medical to Participate in the 2023 Cantor Global Healthcare Conference
(GlobeNewswire)
Sep-06-23 07:23PM
Profound Medical Announces At-the-Market Offering of up to US$30,000,000
(GlobeNewswire) +6.50%
Aug-09-23 04:05PM
Profound Medical Announces Second Quarter 2023 Financial Results
(GlobeNewswire)
Aug-02-23 04:30PM
Profound Medical to Release Second Quarter 2023 Financial Results on August 9 Conference Call to Follow
(GlobeNewswire)
Jun-02-23 01:40PM
Profound Medical Announces New CPT® Category 1 Codes from the AMA for TULSA to Treat Prostate Diseases
(GlobeNewswire) +10.30%
May-30-23 08:00AM
Profound Medical Announces Upcoming Investor Events
(GlobeNewswire) +5.29%
May-18-23 08:00AM
Profound Medical to Participate in A.G.P.s Virtual Healthcare Conference
(GlobeNewswire)
May-17-23 04:15PM
Profound Medical Annual and Special Meeting of Shareholders Voting Results
(GlobeNewswire)
May-10-23 04:05PM
Profound Medical Announces First Quarter 2023 Financial Results
(GlobeNewswire)
May-01-23 04:30PM
TULSA Procedure Featured in the Scientific Program at the American Urological Association 2023 Annual Meeting
(GlobeNewswire) +5.60%
Apr-19-23 04:30PM
Profound Medical to Release First Quarter 2023 Financial Results on May 10 Conference Call to Follow
(GlobeNewswire) +6.07%
04:15PM
Profound Medical to to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
(GlobeNewswire)
Mar-07-23 04:05PM
Profound Medical Announces Fourth Quarter and Full Year 2022 Financial Results
(GlobeNewswire) -5.56%
Mar-01-23 04:30PM
Profound Medical to Present at the 43rd Annual Cowen Health Care Conference
(GlobeNewswire)
Feb-14-23 04:30PM
Profound Medical to Release Fourth Quarter and Full Year 2022 Financial Results on March 7 Conference Call to Follow
(GlobeNewswire)
Nov-08-22 04:30PM
Profound Medical to Present at the 2022 Jefferies London Healthcare Conference
(GlobeNewswire)
Nov-03-22 04:05PM
Profound Medical Announces Third Quarter 2022 Financial Results
(GlobeNewswire) +18.62%
Oct-13-22 04:30PM
Profound Medical to Release Third Quarter 2022 Financial Results on November 3 Conference Call to Follow
(GlobeNewswire)
Sep-26-22 08:00AM
Four Year Follow-Up Data from Profound Medicals TACT Pivotal Clinical Trial Confirm Durable and Stable Positive Trends Following Treatment with TULSA-PRO® of Men with Localized Prostate Cancer
(GlobeNewswire)
Sep-15-22 08:00AM
Profound Medical Announces Changes to its Commercial Organization to Support Continued Growth
(GlobeNewswire)
Sep-06-22 04:30PM
Profound Medical to Participate in September Investor Conferences
(GlobeNewswire) -14.11%
Sep-02-22 12:05PM
Profound Medical Provides TULSA-PRO® Reimbursement Update
(GlobeNewswire) -5.30%
Aug-04-22 04:05PM
Profound Medical Announces Second Quarter 2022 Financial Results
(GlobeNewswire) -20.65%
Jul-14-22 04:30PM
Profound Medical to Release Second Quarter 2022 Financial Results on August 4 Conference Call to Follow
(GlobeNewswire) +8.76%
Jun-16-22 04:30PM
Profound Medical to Participate in the Cowen 7th Annual FutureHealth Conference
(GlobeNewswire)
Jun-07-22 07:56AM
What You Need To Know About Profound Medical Corp.'s (TSE:PRN) Investor Composition
(Simply Wall St.)
Jun-02-22 04:30PM
Profound Medical to Participate in the 2022 Jefferies Global Healthcare Conference
(GlobeNewswire) +6.36%
May-18-22 05:43PM
Profound Medical Annual and Special Meeting of Shareholders Voting Results
(GlobeNewswire)
04:30PM
Profound Medical Clarifies Recent Insider Buying
(GlobeNewswire)
May-17-22 05:25PM
TULSA-PRO® Was Front and Center at AUA2022
(GlobeNewswire)
May-15-22 08:08AM
Trade Alert: The Independent Lead Director Of Profound Medical Corp. (TSE:PRN), Brian Ellacott, Has Just Spent US$459k Buying 278% More Shares
(Simply Wall St.)
May-09-22 04:05PM
Profound Medical Announces First Quarter 2022 Financial Results
(GlobeNewswire) -7.59% +5.02%
Apr-25-22 04:30PM
Profound Medical to Participate in the 2022 Bloom Burton & Co. Healthcare Investor Conference
(GlobeNewswire)
Apr-18-22 04:30PM
Profound Medical to Release First Quarter 2022 Financial Results on May 9 Conference Call to Follow
(GlobeNewswire) -8.46%
Mar-04-22 04:48AM
Companies Like Profound Medical (TSE:PRN) Are In A Position To Invest In Growth
(Simply Wall St.)
Mar-03-22 04:03PM
Profound Medical Announces Fourth Quarter and Full Year 2021 Financial Results
(GlobeNewswire) -6.85%
Mar-02-22 08:00AM
Profound Medical to Participate in March Investor Conferences
(GlobeNewswire)
Mar-01-22 07:00AM
Profound Medicals TULSA-PRO® Now Compatible with GE Healthcares 3T MRI Scanners
(GlobeNewswire)
Feb-24-22 03:00PM
Profound Medical (PROF) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
(Zacks)
Feb-10-22 04:30PM
Profound Medical to Release Fourth Quarter and Full Year 2021 Financial Results on March 3 Conference Call to Follow
(GlobeNewswire) -5.23% -5.20%
Feb-08-22 04:30PM
Profound Medical to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Virtual Conference
(GlobeNewswire)
Jan-18-22 07:48AM
Bullish Profound Medical Corp. (TSE:PRN) insiders filled their treasuries with US$782k worth of stock over last year
(Simply Wall St.)
07:33AM
Profound Medical Announces First Patients Treated in Prospective, Randomized Clinical Trial Comparing the TULSA Procedure to Radical Prostatectomy
(GlobeNewswire)
Jan-05-22 08:00AM
Kenneth Knudson Joins Profound Medical as Chief Commercial Officer
(GlobeNewswire) +5.89%
Dec-03-21 12:23PM
Do Institutions Own Profound Medical Corp. (TSE:PRN) Shares?
(Simply Wall St.)
Nov-04-21 04:03PM
Profound Medical Announces Third Quarter 2021 Financial Results
(GlobeNewswire) -16.61%
Nov-01-21 04:30PM
Profound Medical to Participate in November Virtual Investor Conferences
(GlobeNewswire)
Profound Medical Corp. engages in developing, manufacturing, and marketing of therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. Its platforms offer clinicians and patients incision-free alternatives to current standards of care, which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Goodman AbbeyOfficerNov 12 '24Proposed Sale8.1113,014105,544Nov 12 01:52 PM
Jordan-Cornet HelenSpouseSep 23 '24Proposed Sale7.496314,726Sep 23 04:42 PM
Jordan-Cornet HelenSpouseSep 18 '24Proposed Sale7.495644,224Sep 23 04:03 PM
Jordan-Cornet HelenMember of immediate family of Aug 30 '24Proposed Sale9.9722219Aug 30 12:15 PM
Jordan-Cornet HelenMember of immediate family of Aug 27 '24Proposed Sale9.971051,047Aug 27 01:31 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.